Keywords: ucb, vimpat, goes, sale, usa, belgian, drugmaker

UCB's Vimpat goes on sale in USA

Article | 28 May 2009

Print This

Belgian drugmaker UCB has launched its epilepsy drug Vimpat (lacosamide) in the USA as an add-on therapy for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in